Prevalence of metabolic syndrome in adult population from Zahedan, Southeast Iran

Iranian Journal of Public Health

Volumn 41, Issue 2, 2012, Pages 70-76

  Kaykhaei, M A ^a   Hashemi, M ^a,b   Narouie, B ^c   Shikhzadeh, A ^c   Jahantigh, M ^c   Shirzaei, E ^c   Rezazehi, B ^c   Hoseinian, M ^c   Yousefi, S ^c   Masoudian, S ^c   Emamdadi, A ^c   Alavi, S F ^c   Mashhadi, R ^c   Ansari, H ^d  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Iran; Metabolic syndrome; Waist circumference

Indexed keywords

EID: 84867330567     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reaven GM (2005). The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr, 25:391-406.
2. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G (2005). The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 28:385-90.
3. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J (2007). The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly nondiabetic Finns. Eur Heart J, 28:857-64.
4. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J (2003). Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108:414-9.
5. Sarraf-Zadegan N, Boshtam M, Malekafzali H, Bashardoost N, Sayed-Tabatabaei FA, Rafiei M, Khalili A, Mostafavi S, Khami M, Hassanvand R (1999). Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. Acta Cardiol, 54:327-33.
6. Ford ES (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care, 28:1769-78.
7. Zabetian A, Hadaegh F, Azizi F (2007). Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract, 77:251-7.
8. Hadaegh F, Zabetian A, Tohidi M, Ghasemi A, Sheikholeslami F, Azizi F (2009). Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore, 38:142-9.
9. Hadaegh F, Esmaillzadeh A, Azizi F (2007). Metabolic risks in individuals with normal body mass index and normal waist circumference. Eur J Cardiovasc Prev Rehabil, 14:200-7.
10. Esteghamati A, Ashraf H, Rashidi A, Meysamie A (2008). Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract, 82:104-7.
11. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285:2486-97.
12. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [article online]. www.idf.org.
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. Circulation, 120:1640-5.
14. Mirhosseini NZ, Yusoff NA, Shahar S, Parizadeh SM, Mobarhen MG, Shakery MT (2009). Prevalence of the metabolic syndrome and its influencing factors among adolescent girls inMashhad, Iran. Asia Pac J Clin Nutr, 18:131-6.
15. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009). First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care, 32:1092-7.
16. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F (2006). High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring), 14:377-82.
17. Nezhad MA, Ghayour-Mobarhan M, Parizadeh SM, Safarian M, Esmaeili H, Khodaei GH, Kazemi-Bajestani SM, Hosseini SJ, Jooya M, Ferns GA (2008). Metabolic syndrome: its prevalence and relationship to socioeconomic parameters in an Iranian population. Nutr Metab Cardiovasc Dis, 18:e11-2.
18. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract, 61:29-37.
19. Waterhouse DF, McLaughlin AM, Sheehan F, O'Shea D (2009). An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population. Ir J Med Sci, 178:161-66.
20. Hydrie MZ, Shera AS, Fawwad A, Basit A, Hussain A (2009). Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. Metab Syndr Relat Disord, 7:119-24.
21. Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO (2009). Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a populationbased study. Metab Syndr Relat Disord, 7:221-9.
22. Park HS, Park CY, Oh SW, Yoo HJ (2008). Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev, 9:104-7.
23. Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, Miyashita Y, Ebara F, Ishikawa S, Tajima N (2008). Low prevalence of metabolic syndrome and its components in rural Japan. Tohoku J Exp Med, 216:69-75.